Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Clinical trial NCT00689936 · COMPLETED
Trial details
- NCT number
- NCT00689936
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-21
- Primary completion
- 2016-07-14
- Enrollment
- 1623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.